Berkshire Sterile client receives FDA approval on product indicated to reduce risk of hearing loss for childhood cancer patients
Globe Newswire On September 21st, 2022, Berkshire Sterile Manufacturing’s (BSM) client, Fennec Pharmaceuticals Inc., received FDA approval of their drug product, PEDMARK – a sodium thiosulfate Injection with an indication…
Berkshire Sterile achieves its first commercial drug approval by the FDA
Lee, MA, Mar 22, 2022 (GLOBE NEWSWIRE) -- On March 1, 2022, a long-term client of Berkshire Sterile Manufacturing (BSM) announced the FDA approval of their Abbreviated New Drug Application…
